Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects
The Journal of Pathology · 2023-08 · 260 (5) · 551-563
DOI: 10.1002/path.6163 ↗At a glance
Übersichtsarbeit in The Journal of Pathology, published online on 2023-08-14. Written by Gregory Verghese and 10 co-authors. Institution: School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK. Major MEDLINE topics: Artificial Intelligence, Neoplasms. Cited 85 times so far (Crossref); 94 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, NCI NIH HHS, Medical Research Council.
Abstract (original language)
Computational pathology refers to applying deep learning techniques and algorithms to analyse and interpret histopathology images. Advances in artificial intelligence (AI) have led to an explosion in innovation in computational pathology, ranging from the prospect of automation of routine diagnostic tasks to the discovery of new prognostic and predictive biomarkers from tissue morphology. Despite the promising potential of computational pathology, its integration in clinical settings has been limited by a range of obstacles including operational, technical, regulatory, ethical, financial, and cultural challenges. Here, we focus on the pathologists’ perspective of computational pathology: we map its current translational research landscape, evaluate its clinical utility, and address the more common challenges slowing clinical adoption and implementation. We conclude by describing contemporary approaches to drive forward these techniques. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
- The Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
- Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
- Guy's Cancer, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Department of Cellular Pathology, Guy's and St Thomas NHS Foundation Trust, London, UK.
- Head & Neck Pathology, Guy's and St Thomas NHS Foundation Trust, London, UK.
ORCID profiles: Gregory Verghese, Jochen K Lennerz, Selvam Thavaraj, Kalliopi P Siziopikou, Threnesan Naidoo, Swapnil Rane, Roberto Salgado, Anita Grigoriadis
Funding
- Wellcome Trust
- NCI NIH HHS
- Medical Research Council
- Cancer Research UK
- Breast Cancer Now
- Breast Cancer Research Foundation
- National Institutes of Health
Cite
APA
Verghese, G., Lennerz, J. K., Ruta, D., Ng, W., Thavaraj, S., Siziopikou, K. P., Naidoo, T., Rane, S., Salgado, R., Pinder, S. E., & Grigoriadis, A. (2023). Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects. The Journal of Pathology, 260(5), 551-563. https://doi.org/10.1002/path.6163
Vancouver
Verghese G, Lennerz JK, Ruta D, Ng W, Thavaraj S, Siziopikou KP, et al. Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects. The Journal of Pathology. 2023;260(5):551-563. doi:10.1002/path.6163
BibTeX
@article{Verghese2023,
author = {Verghese, Gregory and Lennerz, Jochen K and Ruta, Danny and Ng, Wen and Thavaraj, Selvam and Siziopikou, Kalliopi P and Naidoo, Threnesan and Rane, Swapnil and Salgado, Roberto and Pinder, Sarah E and Grigoriadis, Anita},
title = {Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects},
journal = {The Journal of Pathology},
year = {2023},
volume = {260},
number = {5},
pages = {551--563},
doi = {10.1002/path.6163}
}
EUVIMED